Cartesian Therapeutics RNAC
NASDAQ RNAC
$6.33 -0.09 (-1.40%)
As of: Oct 22, 2026 · 9:30 AM EDT

Cartesian Therapeutics (RNAC) Current Debt (2017)

Updated

Analysis

Cartesian Therapeutics (RNAC) Current Debt (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,149.64 Bn 1,118.23 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 626.55 Bn 545.08 Bn 17.26 Bn -5.75 Bn
3 AbbVie 498.79 Bn 471.91 Bn 12.70 Bn -
4 Merck 371.66 Bn 326.04 Bn 12.21 Bn -
5 Novartis Ag 299.96 Bn 263.95 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 263.22 Bn 236.91 Bn 12.86 Bn -
7 Amgen 237.03 Bn 192.43 Bn 7.24 Bn -
8 Gilead Sciences 191.20 Bn 165.40 Bn 6.22 Bn -
9 Pfizer 170.83 Bn 117.47 Bn 10.94 Bn 64.00 Mn
10 Cartesian Therapeutics 186.53 Mn -348.24 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 -42,000.00
API Access

Cartesian Therapeutics Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=RNAC&period=max&api_key=YOUR_API_KEY